Post-Conference Day: Thursday, May 2, 2024

IP Patenting & Commercial Partnerships Post-Conference Day

A unique chance to enhance your understanding of the intellectual property landscape in the LNP field, gaining clarity on collaborative practices while ensuring compliance with legal boundaries. Additionally, discover strategies to present yourself as a desirable collaborator to prominent biopharmaceutical entities actively seeking productive partnerships with the biotech and academic sectors

9:30 am Chair’s Opening Address

9:45 am An Overview of the LNP IP Field – Where Are We Now?


  • Spotlighting the properties of LNP which create unique IP challenges
  • Spanning the breadth of LNP development from discovery to manufacturing to understand hotspots for IP bottlenecks
  • Suggesting future strategy to enable the LNP field to progress with collaborative discussion without the compromise of IP

10:15 am Case Study: How is a Small Biotech Navigating This Field?

  • Eneda Hoxha Vice President, Intellectual Property & Business Development, ReCode Therapeutics


  • Sharing the current challenges faced when overcoming IP push back
  • Liaising effectively with legal teams to foster positive conversations surrounding data sharing
  • Highlighting success stories witnessed when developing commercial partnerships in the LNP world 

11:00 am Morning Break

12:00 pm Roundtable Discussion: Creating an Open Forum with Drug Developers & IP Consultants & Lawyers to Relay the Roadmap to Improvement

  • Alexander Aust Chief Executive Officer & Consultant, Aust Business Solutions


  • Balancing legal team requirements with desire to progress LNP data sharing
  • Assessing current IP laws across biopharma and biotech and navigating requirements which have potential to be altered
  • Striving for standardization across the field, to create a level playing field for LNP drug development 

1:00 pm Lunch & Networking

2:00 pm Rethinking How to Enter Partnerships & Appear Attractive to Large Pharma

  • Chris Lai Chief Executive Officer and Co-Founder, Metis Pharmaceuticals


  • Effectively translating company status and current goals to large pharma for future collaborations
  • Highlighting the key qualities of ‘partnerable’ companies
  • Translating clearly what large pharma can gain from the partnership in the short term and long term

2:45 pm Navigating Partnerships & Collaborations between Biopharma to Drive Large Scale LNP Development


  • Outlining key product parameters and short-, mid- and long-term goals to assure alignment
  • Showcasing previous success stories of biopharma partnerships to drive LNP research and development
  • Overcoming the legal challenges of collaborations to foster a partnership of clarity and transparency 

3:15 pm Chair’s Closing Remarks

To Access the Main 2-day Agenda, Download the Full Event Guide HERE